Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAP3K14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CEBPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYRK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JUP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFLAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927204 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CAV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RARG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3190 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFI35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLRX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT1X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFIH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on